Jinling Pharmaceutical Co Ltd (000919) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.015x

Based on the latest financial reports, Jinling Pharmaceutical Co Ltd (000919) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥74.01 Million ≈ $10.83 Million USD) by net assets (CN¥4.85 Billion ≈ $709.28 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 000919 company net worth for the company's overall valuation and market capitalisation.

Jinling Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Jinling Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jinling Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jinling Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 000919 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Oculis Holding AG Ordinary shares NASDAQ:OCS	-0.081x
Guangdong Green Precision Components Co. Ltd. SHE:300968	-0.033x
ION Exchange (India) Limited NSE:IONEXCHANG	-0.006x
GnCenergy Co Ltd KQ:119850	0.124x
Leong Hup International Berhad KLSE:6633	-0.010x
Korea District Heating Corp KO:071320	0.126x
Zhangjiagang Furui Special Equip SHE:300228	0.106x
Allied Electronics Corporation Ltd JSE:AEL	0.163x

Annual Cash Flow Conversion Efficiency for Jinling Pharmaceutical Co Ltd (1999–2024)

The table below shows the annual cash flow conversion efficiency of Jinling Pharmaceutical Co Ltd from 1999 to 2024. View today's stock price for Jinling Pharmaceutical Co Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥4.85 Billion ≈ $709.50 Million	CN¥154.19 Million ≈ $22.56 Million	0.032x	-26.26%
2023-12-31	CN¥3.68 Billion ≈ $539.22 Million	CN¥158.92 Million ≈ $23.26 Million	0.043x	-39.97%
2022-12-31	CN¥3.63 Billion ≈ $530.75 Million	CN¥260.59 Million ≈ $38.13 Million	0.072x	-13.04%
2021-12-31	CN¥3.53 Billion ≈ $517.22 Million	CN¥292.03 Million ≈ $42.73 Million	0.083x	-8.93%
2020-12-31	CN¥3.43 Billion ≈ $502.38 Million	CN¥311.46 Million ≈ $45.58 Million	0.091x	-33.30%
2019-12-31	CN¥3.42 Billion ≈ $501.14 Million	CN¥465.85 Million ≈ $68.17 Million	0.136x	+1.78%
2018-12-31	CN¥3.25 Billion ≈ $475.00 Million	CN¥433.83 Million ≈ $63.48 Million	0.134x	-7.89%
2017-12-31	CN¥3.05 Billion ≈ $446.88 Million	CN¥443.11 Million ≈ $64.84 Million	0.145x	+360.72%
2016-12-31	CN¥3.05 Billion ≈ $446.75 Million	CN¥96.15 Million ≈ $14.07 Million	0.031x	-56.65%
2015-12-31	CN¥2.92 Billion ≈ $427.95 Million	CN¥212.45 Million ≈ $31.09 Million	0.073x	-33.36%
2014-12-31	CN¥2.75 Billion ≈ $402.55 Million	CN¥299.89 Million ≈ $43.88 Million	0.109x	+3.48%
2013-12-31	CN¥2.57 Billion ≈ $376.72 Million	CN¥271.21 Million ≈ $39.69 Million	0.105x	+11.91%
2012-12-31	CN¥2.47 Billion ≈ $360.82 Million	CN¥232.12 Million ≈ $33.97 Million	0.094x	+26.66%
2011-12-31	CN¥2.33 Billion ≈ $340.26 Million	CN¥172.82 Million ≈ $25.29 Million	0.074x	-8.07%
2010-12-31	CN¥2.20 Billion ≈ $321.83 Million	CN¥177.81 Million ≈ $26.02 Million	0.081x	-11.82%
2009-12-31	CN¥2.05 Billion ≈ $300.70 Million	CN¥188.41 Million ≈ $27.57 Million	0.092x	-43.58%
2008-12-31	CN¥1.88 Billion ≈ $274.89 Million	CN¥305.26 Million ≈ $44.67 Million	0.162x	+168.31%
2007-12-31	CN¥1.95 Billion ≈ $285.26 Million	CN¥118.06 Million ≈ $17.28 Million	0.061x	-25.72%
2006-12-31	CN¥1.70 Billion ≈ $248.57 Million	CN¥138.50 Million ≈ $20.27 Million	0.082x	+16.56%
2005-12-31	CN¥1.56 Billion ≈ $228.64 Million	CN¥109.29 Million ≈ $15.99 Million	0.070x	-35.69%
2004-12-31	CN¥1.47 Billion ≈ $214.99 Million	CN¥159.81 Million ≈ $23.38 Million	0.109x	-7.32%
2003-12-31	CN¥1.38 Billion ≈ $201.81 Million	CN¥161.86 Million ≈ $23.69 Million	0.117x	+11.72%
2002-12-31	CN¥1.24 Billion ≈ $181.58 Million	CN¥130.36 Million ≈ $19.08 Million	0.105x	+26.04%
2001-12-31	CN¥1.11 Billion ≈ $162.39 Million	CN¥92.49 Million ≈ $13.53 Million	0.083x	-61.78%
2000-12-31	CN¥1.06 Billion ≈ $155.22 Million	CN¥231.31 Million ≈ $33.85 Million	0.218x	+458.19%
1999-12-31	CN¥1.02 Billion ≈ $148.96 Million	CN¥39.77 Million ≈ $5.82 Million	0.039x	--

About Jinling Pharmaceutical Co Ltd

SHE:000919 China Drug Manufacturers - Specialty & Generic

Market Cap

$587.91 Million

CN¥4.02 Billion CNY

Market Cap Rank

#11515 Global

#3265 in China

Share Price

CN¥6.46

Change (1 day)

-0.15%

52-Week Range

CN¥5.78 - CN¥8.91

All Time High

CN¥16.21